Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wharton Jelly Stem Cells for Diabetic Erectile Dysfunction
NCT03751735Phase 2Completed
- Start
- Jan 2017
- Primary completion
- Jan 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of wharton's jelly mesenchymal stromal cells in erectile dysfunction (ED). Started Jan 2017; status: completed.
02
Drugs
wharton's jelly mesenchymal stromal cells
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT03751735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03751735.